CervoMed annual revenue
2010
2011
2012
2013
2022
2023
2024
2025
CervoMed Revenue Growth & History (CRVO)
CervoMed reported $4.0M in revenue for fiscal 2025, a decrease of 58.86% from the previous fiscal year.
View full CervoMed company overviewCervoMed annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.0M | −$5.7M | −58.86% |
| 2024 | 2024-12-31 | $9.7M | $2.6M | +36.29% |
| 2023 | 2023-12-31 | $7.1M | $7.1M | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2013 | 2013-12-31 | $71,667 | −$302,875 | −80.87% |
| 2012 | 2012-12-31 | $374,542 | −$195,934 | −34.35% |
| 2011 | 2011-12-31 | $570,476 | $530,287 | +1319.48% |
| 2010 | 2010-12-31 | $40,189 | — | — |
CervoMed quarterly revenue
Q2.10
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$1.8M | −100.00% |
| Q1 2026 | 2026-03-31 | $0 | −$1.9M | −100.00% |
| Q4 2025 | 2025-12-31 | $8,726 | −$2.2M | −99.60% |
| Q3 2025 | 2025-09-30 | $322,569 | −$1.6M | −83.37% |
| Q2 2025 | 2025-06-30 | $1.8M | −$1.5M | −46.56% |
| Q1 2025 | 2025-03-31 | $1.9M | −$429,759 | −18.31% |
| Q4 2024 | 2024-12-31 | $2.2M | −$328,576 | −13.19% |
| Q3 2024 | 2024-09-30 | $1.9M | $413,269 | +27.07% |
| Q2 2024 | 2024-06-30 | $3.3M | $1.6M | +91.23% |
| Q1 2024 | 2024-03-31 | $2.3M | $939,382 | +66.72% |
| Q4 2023 | 2023-12-31 | $2.5M | — | — |
| Q3 2023 | 2023-09-30 | $1.5M | $1.5M | — |
| Q2 2023 | 2023-06-30 | $1.7M | — | — |
| Q1 2023 | 2023-03-31 | $1.4M | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q4 2013 | 2013-12-31 | $0 | $71,668 | +100.00% |
| Q3 2013 | 2013-09-30 | $0 | −$143,334 | −100.00% |
| Q2 2013 | 2013-06-30 | $71,667 | −$71,667 | −50.00% |
| Q1 2013 | 2013-03-31 | $0 | −$159,542 | −100.00% |
| Q4 2012 | 2012-12-31 | −$71,668 | — | — |
| Q3 2012 | 2012-09-30 | $143,334 | −$106,867 | −42.71% |
| Q2 2012 | 2012-06-30 | $143,334 | $143,334 | — |
| Q1 2012 | 2012-03-31 | $159,542 | — | — |
| Q3 2011 | 2011-09-30 | $250,201 | — | — |
| Q2 2011 | 2011-06-30 | $0 | $0 | — |
| Q2 2010 | 2010-06-30 | $0 | — | — |
CervoMed revenue growth trends
CervoMed's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review CervoMed source filings ↗